53,307 Shares in Phibro Animal Health Co. (NASDAQ:PAHC) Bought by Cubist Systematic Strategies LLC

Cubist Systematic Strategies LLC bought a new stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 53,307 shares of the company's stock, valued at approximately $1,119,000. Cubist Systematic Strategies LLC owned approximately 0.13% of Phibro Animal Health as of its most recent filing with the SEC.

A number of other large investors have also recently modified their holdings of PAHC. Hussman Strategic Advisors Inc. acquired a new stake in shares of Phibro Animal Health in the 4th quarter valued at $2,205,000. Alliancebernstein L.P. boosted its holdings in shares of Phibro Animal Health by 357.1% in the 4th quarter. Alliancebernstein L.P. now owns 130,000 shares of the company's stock valued at $2,730,000 after purchasing an additional 101,560 shares in the last quarter. Prudential Financial Inc. boosted its holdings in shares of Phibro Animal Health by 405.8% in the 4th quarter. Prudential Financial Inc. now owns 120,655 shares of the company's stock valued at $2,534,000 after purchasing an additional 96,800 shares in the last quarter. American Century Companies Inc. boosted its holdings in shares of Phibro Animal Health by 18.0% in the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock valued at $13,348,000 after purchasing an additional 96,787 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA acquired a new stake in shares of Phibro Animal Health in the 4th quarter valued at $2,020,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Morgan Stanley raised their target price on Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a report on Thursday, May 8th. StockNews.com raised Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, Barclays raised their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a report on Monday, February 10th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $20.00.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC traded up $0.17 during mid-day trading on Friday, hitting $24.00. 306,154 shares of the stock traded hands, compared to its average volume of 196,805. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55. The company has a market cap of $972.82 million, a PE ratio of 50.00, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. The firm has a 50 day simple moving average of $20.08 and a two-hundred day simple moving average of $21.88.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The company had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. As a group, equities research analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.00%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio is currently 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.